Oxazolidinone for treatment of inffections with mycobacterium tuberculosis
AssigneesThe Johns Hopkins University, University of St. Thomas
InventorsGyanu Lamichhane, J. Thomas Ippoliti
Life of this patent
Estimating the term…
Abstract
The present invention is a method of treating or preventing Mycobacterium tuberculosis infection in a subject by administering to the subject an effective amount of oxazolidinone, specifically (N—(((S)-3-(dibenzo[b,e][1,4]dioxin-7-yl)-2-oxooxazolidin-5-yl)methyl)acetamide) or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
Claims5
-8. (canceled)
A method for treating or preventing a Staphylococcus aureus or an Enterococcus faecalis infection in a subject in need thereof, the method comprising administering to the subject an effective amount of (N—(((S)-3-(dibezo[b,e][1,4]dioxin-7-yl)-2-oxooxazolidin-5-yl)methyl)acetamide) or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
Dependencies are inferred from the claim text.